Akebia Therapeutics AKBA
NASDAQ AKBA
$0.92 +0.03 (+3.81%)
As of: Sep 30, 2026 · 1:58 PM EDT

Akebia Therapeutics, Inc. (AKBA) EBIT (2013 - 2026)

Updated

Akebia Therapeutics (AKBA) reported EBIT of -$6.33 million for Q2 2026, compared with $14.09 million a year earlier.

Analysis

Akebia Therapeutics, Inc. (AKBA) EBIT (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Akebia Therapeutics' EBIT came in at -$15.13 million; for FY2025, it was $23.5 million.

  • By year, EBIT came in at -$50.47 million in FY2024, -$46.26 million in FY2023, -$80.78 million in FY2022 and -$264.5 million in FY2021.
  • Five-year quarterly EBIT spans a low of -$65.34 million in Q4 2021 and a high of $34.08 million in Q2 2022.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$4.7 million (Q1 2026), -$8.55 million (Q4 2025) and $4.45 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.33 Mn
Mar 31, 2026 -4.70 Mn
Dec 31, 2025 -8.55 Mn
Sep 30, 2025 4.45 Mn
Jun 30, 2025 14.09 Mn
Mar 31, 2025 13.51 Mn
Dec 31, 2024 -14.31 Mn
Sep 30, 2024 -12.51 Mn
Jun 30, 2024 -8.73 Mn
Mar 31, 2024 -14.94 Mn
Dec 31, 2023 1.37 Mn
Sep 30, 2023 -13.04 Mn
Jun 30, 2023 -9.00 Mn
Mar 31, 2023 -25.60 Mn
Dec 31, 2022 -4.87 Mn
Sep 30, 2022 -50.41 Mn
Jun 30, 2022 34.08 Mn
Mar 31, 2022 -59.58 Mn
Dec 31, 2021 -65.34 Mn
Sep 30, 2021 -54.89 Mn
API Access

Akebia Therapeutics, Inc. EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=AKBA&period=max&api_key=YOUR_API_KEY